My bookmarksSign up free

2009/700/EC: Commission Decision of 10 September 2009 recognising in principle the completeness of the dossier submitted for detailed examination in view of the possible inclusion of bixafen in Annex I to Council Directive 91/414/EEC (notified under document C(2009) 6771) (Text with EEA relevance)

2009/700/EC: Commission Decision of 10 September 2009 recognising in principle the completeness of the dossier submitted for detailed examination in view of the possible inclusion of bixafen in Annex I to Council Directive 91/414/EEC (notified under document C(2009) 6771) (Text with EEA relevance)

Directive 91/414/EEC · Decision · 4 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Without prejudice to Article 6(4) of Directive 91/414/EEC, the dossier concerning the active substance identified in the Annex to this Decision, which was submitted to the Commission and the Member States with a view to obtaining the inclusion of that substance in Annex I to that Directive, satisfies in principle the data and information requirements set out in Annex II to that Directive. The dossier also satisfies the data and information requirements set out in Annex III to that Directive in respect of one plant protection product containing the active substance, taking into account the uses proposed.

Article 2

The rapporteur Member State shall pursue the detailed examination for the dossier referred to in Article 1 and shall communicate to the Commission the conclusions of its examination accompanied by a recommendation on the inclusion or non-inclusion in Annex I to Directive 91/414/EEC of the active substance referred to in Article 1 and any conditions for that inclusion as soon as possible and at the latest within a period of 1 year from the date of publication of this Decision in the Official Journal of the European Union .

Article 3

This Decision is addressed to the Member States.

Supplementary provisions

ANNEXSupplementary provisions

ANNEX ACTIVE SUBSTANCE CONCERNED BY THIS DECISION Common name, CIPAC identification number Applicant Date of application Rapporteur Member State Bixafen CIPAC-No: not attributed yet Bayer CropScience 8 October 2008 UK

Other acts of the same type
Commission Decision (EU) 2025/1235 of 24 March 2025 on the measure State aid SA.54155 (2021/NN) implemented by Spain – Arbitration award to Antin (notified under document C(2025) 1781)Commission Implementing Decision (EU) 2025/526 of 21 March 2025 designating a Union testing facility for electromagnetic compatibility in accordance with Regulation (EU) 2019/1020 of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2025/540 of 19 March 2025 amending the Annex to Implementing Decision (EU) 2023/2447 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States (notified under document C(2025) 1818)Commission Decision (EU) 2025/543 of 19 March 2025 on the compliance of the revised unit rates for air navigation charges set by Italy for year 2024 (notified under document C(2025) 1624)Commission Implementing Decision (EU) 2025/503 of 18 March 2025 laying down rules for the application of Regulation (EU) 2024/1351 of the European Parliament and of the Council, as regards the template to be used by Member States to ensure that their national asylum and migration management strategies are comparable on specific core elementsCouncil Implementing Decision (EU) 2025/539 of 18 March 2025 authorising Estonia to apply a special measure derogating from Article 26(1), point (a), and Articles 168 and 168a of Directive 2006/112/EC on the common system of value added taxCouncil Decision (EU) 2025/542 of 18 March 2025 establishing the position to be taken on behalf of the European Union regarding the decision of the Participants to the Sector Understanding on Export Credits for Civil Aircraft contained in Annex III to the Arrangement on Officially Supported Export Credits on amendments to that Sector UnderstandingCommission Implementing Decision (EU) 2025/485 of 17 March 2025 concerning the extension of the action taken by the Health and Safety Executive of the United Kingdom permitting the making available on the market and use of the biocidal product Biobor JF in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2025) 1565)Commission Implementing Decision (EU) 2025/489 of 17 March 2025 concerning the extension of the action taken by Malta Competition and Consumer Affairs Authority permitting the making available on the market and use of the biocidal product Biobor JF in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2025) 1560)Commission Implementing Decision (EU) 2025/495 of 17 March 2025 concerning the extension of the action taken by the Belgian Federal Public Service Health, Food Chain Safety and Environment permitting the making available on the market and use of the biocidal product Interox SG 35 Plus in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCouncil Implementing Decision (CFSP) 2025/510 of 17 March 2025 implementing Decision 2010/788/CFSP concerning restrictive measures in view of the situation in the Democratic Republic of the CongoCouncil Decision (CFSP) 2025/514 of 17 March 2025 amending Decision (CFSP) 2016/1693 concerning restrictive measures against ISIL (Da’esh) and Al-Qaeda and persons, groups, undertakings and entities associated with them

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next